MANSFIELD – Covidien Plc won a $4.8 million verdict against Applied Medical Resources Corp. for patent infringement last week.
A federal jury in Lufkin, Texas, found that Applied Medical infringed on a Covidien patent in making its Kii and Universal laparoscopic trocars, which are used for minimally invasive surgery.
PBN Branded Content
Rhode Island's Market Has Changed. Developers, Builders, Investors and Sellers Must Change With It.
By Emilio DiSpirito IV License Partner | Engel & Völkers Oceanside Leader | The DiSpirito…
Learn More
Covidien is eying minimally invasive surgery as a key growth driver in the years to come.
Covidien “will continue to vigorously protect our innovations and intellectual property,” Ralph Corradi, vice president of Covidien’s Endomechanical Franchise, said in a statement.
- Advertisement -
